Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
MARKET INSIGHTS
The global Pre-made Library Sequencing Services market was valued at USD 585 million in 2024 and is projected to reach USD 891 million by 2031, exhibiting a CAGR of 6.4% during the forecast period. This growth is attributed to the expanding applications in precision medicine, declining sequencing costs, and increasing pharmaceutical R&D investments. Key players include Novogene, CD Genomics, and BGI, who collectively held approximately 35% market share in 2023.
Pre-made library sequencing involves sequencing pre-constructed genetic libraries that contain DNA, RNA, or other genomic materials ready for analysis. These services are particularly crucial for high-throughput screening applications in drug discovery, functional genomics, and diagnostic development. The technology enables researchers to analyze large sample sets without individual library preparation, significantly reducing turnaround times from weeks to days.
Market growth is further driven by the rising adoption in academic research, increasing prevalence of genetic disorders requiring large-scale screening, and growing pharmaceutical R&D expenditure which reached USD 247 billion globally in 2023. The market shows strongest growth in North America (45% share) followed by Asia-Pacific (32% share), with China emerging as the fastest growing market at 9.1% CAGR.
Rising Demand for Precision Medicine
The increasing adoption of personalized medicine approaches, particularly in oncology and rare disease research, is driving demand for high-quality pre-made sequencing libraries that enable precise genomic analysis at scale.
Growth in Multi-omics Research
Integration of genomic data with other omics technologies requires high-quality sequencing libraries as foundation, driving market growth as researchers seek more comprehensive biological insights through multi-omics approaches.
Next-generation sequencing adoption increased by 42% in clinical research settings last year, creating substantial demand for standardized, pre-made library solutions
Advancements in library preparation technologies, particularly in automation and miniaturization, are enabling more consistent results and reducing hands-on time, making pre-made libraries more attractive to both research and clinical laboratories.
MARKET CHALLENGES
Standardization Across Platforms
Different sequencing platforms (Illumina, Ion Torrent, Nanopore) require different library preparation approaches, creating challenges in developing standardized pre-made solutions that maintain compatibility and performance across platforms while meeting diverse research needs.
Other Challenges
Quality Control Complexity
Ensuring batch-to-batch consistency in pre-made libraries requires sophisticated QC protocols that add to development costs and time, particularly for complex or rare sample types where reference materials are limited.
Sample Integrity Requirements
Maintaining sample integrity from collection through library preparation requires specialized handling that can be challenging to standardize in pre-made formats, particularly for sensitive clinical samples or degraded forensic samples.
High Initial Development Costs
Developing robust, validated pre-made library systems requires significant upfront investment in R&D, quality control systems, and scalability testing, which can be prohibitive for smaller service providers and limits market entry for new players without substantial backing.
Emerging Markets Expansion
Developing regions with growing research infrastructure present significant opportunities as their sequencing capacity grows. Countries establishing new genomic centers require standardized, reliable library preparation solutions that pre-made services can provide, with the Asian market projected to grow at 19.3% annually through 2028.
Integrated Service Offerings
Combining pre-made library services with sequencing, data analysis, and interpretation creates comprehensive solutions that command premium pricing and higher margins. The integration trend is particularly strong in clinical service providers and contract research organizations expanding their service menus.
| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
DNA sequencing services represent the leading segment due to higher demand for genomic analysis in research and clinical applications, with RNA sequencing gaining traction for transcriptome studies and personalized medicine approaches. |
| By Application |
|
Academic research remains the dominant segment as universities and research institutes extensively utilize sequencing services for genomic studies, while clinical diagnostics shows the fastest growth due to increasing adoption of precision medicine and genetic testing. |
| By End User |
|
Research institutions represent the largest segment due to extensive genomic research initiatives and large-scale sequencing projects, while hospitals show significant growth potential as genetic testing becomes integral to clinical practice and personalized treatment plans. |
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
Illumina Inc. (USA) continues to dominate the pre-made library sequencing services market with its comprehensive suite of library preparation kits and sequencing services, capturing significant market share through its established distribution network and continuous innovation in next-generation sequencing technologies.
Other major players including Thermo Fisher Scientific Inc. (USA), Agilent Technologies Inc. (USA), and QIAGEN N.V. (Netherlands) have significantly expanded their market presence through strategic acquisitions and partnerships, strengthening their product portfolios in targeted sequencing and custom library preparation services.
The competitive landscape is further intensified by the entry of BGI Group (China) and PerkinElmer Inc. (USA), who are aggressively expanding their geographical footprint through new service offerings and enhanced customer support programs, particularly in the Asia-Pacific region.
Specialized players such as GENEWIZ (USA) and Integrated DNA Technologies Inc. (USA) are focusing on niche applications including single-cell sequencing and metagenomics, offering highly customized solutions that address specific research needs and drive innovation in the market.
List of Key Pre-made Library Sequencing Services CompaniesIllumina Inc. (USA)
BGI Group (China)
Agilent Technologies Inc. (USA)
QIAGEN N.V. (Netherlands)
PerkinElmer Inc. (USA)
GENEWIZ (USA)
Integrated DNA Technologies Inc. (USA)
The pre-made library sequencing services market is experiencing significant growth due to increasing demand for standardized, high-throughput solutions that reduce preparation time and minimize technical variability. Research institutions and pharmaceutical companies are increasingly outsourcing these services to specialized providers who offer standardized protocols and quality-controlled library preparations, driving a 28% year-over-year market growth in this segment.
Other TrendsAutomation and Robotics Integration
Leading service providers are integrating robotic systems for library preparation, enabling higher throughput and reduced human error. Automated liquid handling systems now handle 85% of routine library preparation steps, with an average 40% reduction in manual handling time compared to semi-automated approaches. This shift is particularly prominent in academic core facilities and contract research organizations.
The market is seeing increased demand for application-specific pre-made libraries, particularly for single-cell sequencing and metagenomics studies. Customization options now account for 32% of total service offerings, with providers developing specialized kits that maintain library integrity while reducing preparation time by up to 60%. This trend is driven by the need for standardized results across multiple research sites and clinical settings.
Service providers are increasingly offering bundled services including library preparation, sequencing, and data analysis as integrated packages. This approach addresses the need for end-to-end solutions in translational research and drug discovery programs, with 67% of major academic centers now utilizing at least two services from the same provider to maintain consistency in their multi-omics research pipelines.
Regional Analysis: Pre-made Library Sequencing Services MarketEurope
Europe represents the second largest market for pre-made library sequencing services, characterized by strong research infrastructure across multiple countries. The region benefits from well-established genomics research programs, particularly in the UK, Germany, and France, where academic and research institutions maintain strong collaborations with sequencing service providers. The market shows particular strength in specialized applications including agricultural genomics, rare disease research, and biodiversity studies, with service providers offering specialized libraries tailored to European research priorities and collaborative projects.
Asia-Pacific
The Asia-Pacific region demonstrates the fastest growth in pre-made library sequencing services, driven by increasing research expenditure and expanding biotechnology sectors in China, Japan, South Korea, and India. The market is characterized by growing adoption in academic and research institutions, with increasing outsourcing of sequencing services to specialized providers. Government initiatives in genomics research, particularly in China and South Korea, contribute to market growth, while service providers increasingly offer specialized libraries adapted to regional research priorities including agricultural applications and disease genomics.
South America
South America represents an emerging market for pre-made library sequencing services, with growth primarily driven by research institutions in Brazil, Argentina, and Chile. The market benefits from increasing research collaboration with North American and European institutions, leading to adoption of standardized methods and services. While the market remains smaller than other regions, growth rates are significant as research infrastructure develops and sequencing applications expand into areas including biodiversity studies and agricultural research.
Middle East & Africa
The Middle East and Africa represent developing markets for pre-made library sequencing services, with growth concentrated in South Africa, Israel, and a few Gulf states. Market development is characterized by partnerships with international service providers and gradual adoption in academic and research institutions. The market shows particular potential in applications including infectious disease research and agricultural genomics, though overall adoption remains limited compared to other regions due to infrastructure constraints and competing research priorities.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
<28strong>Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
28li>By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends28
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges28p>
Opportunities & Recommendations
High-growth 28segments
28Investment hotspots
Strategic suggestions for stakeholders
28Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> Global pre-made library sequencing services market was valued at USD 585 million in 2024 and is expected to reach USD 891 million by 2031.
-> Key players include Novogene, CD Genomics, LC Sciences, Admera Health, BGI, BMKGENE, Psomagen, Inc., ACGT Inc., MedGenome, and Innomics, among others.
-> Key growth drivers include precision medicine applications, declining sequencing costs, and increasing pharmaceutical R&D investments.
-> North America is the dominant market with 45% share, while Asia-Pacific is the fastest-growing region.
-> Emerging trends include high-throughput screening, automation in library preparation, and growing adoption in drug discovery applications.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates